Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Laurens who wrote (2530)	5/17/1998 11:38:00 AM
From: Anthony Wong	Respond to of 9523

Laurents, thanks for keeping us up to date on Viagra in Europe. It would be interesting to see how much more hoopla Viagra would create once it got approval in most European countries later this year. If it is available in Germany in September, revenue from sales in Europe would start coming last quarter of this year.

To: Laurens who wrote (2530)	5/17/1998 6:43:00 PM
From: gial	Respond to of 9523

Viagra is generating a huge interest throughout the Asian countries. If people in this region are willing to spend millions of dollars on exotic, medically unproven herbs and animal parts to remedy ED, then how willing are they to demand this clinically proven drug ? Once Viagra clears the the health authorities of the various countries, its sales overseas is truly unmeasurable.